Skip to main content

Table 4 Recurrence rates according to the combination of TNM stage, CoV SUV, and SLR

From: Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study

  

TNM stage

Stage I-II

Stage III-IV

CoV SUV and SLR

CoV SUV > 0.25 and SLR < 0.83

1/19

(5.3%)

1/15

(6.7%)

CoV SUV ≤ 0.25 or SLR ≥ 0.83

5/32

(15.6%)

6/21

(28.6%)

CoV SUV ≤ 0.25 and SLR ≥ 0.83

4/12

(33.3%)

13/20

(65.0%)

  1. CoV, coefficient of variation; SLR, spleen-to-liver uptake ratio; SUV, standardized uptake value
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us